Creative Medical Technology (NASDAQ:CELZ – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.
Earnings and Valuation
This table compares Creative Medical Technology and Nurix Therapeutics”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Creative Medical Technology | $10,000.00 | 396.12 | -$5.99 million | ($1.99) | -0.30 |
| Nurix Therapeutics | $83.98 million | 20.66 | -$264.46 million | $2.31 | 6.87 |
Creative Medical Technology has higher earnings, but lower revenue than Nurix Therapeutics. Creative Medical Technology is trading at a lower price-to-earnings ratio than Nurix Therapeutics, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
1.4% of Creative Medical Technology shares are held by institutional investors. 1.0% of Creative Medical Technology shares are held by company insiders. Comparatively, 6.7% of Nurix Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Risk & Volatility
Creative Medical Technology has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500. Comparatively, Nurix Therapeutics has a beta of 1.8, suggesting that its stock price is 80% more volatile than the S&P 500.
Profitability
This table compares Creative Medical Technology and Nurix Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Creative Medical Technology | N/A | -100.39% | -94.90% |
| Nurix Therapeutics | 42.01% | 49.34% | 38.61% |
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Creative Medical Technology and Nurix Therapeutics, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Creative Medical Technology | 1 | 0 | 1 | 0 | 2.00 |
| Nurix Therapeutics | 1 | 0 | 14 | 0 | 2.87 |
Nurix Therapeutics has a consensus target price of $34.43, indicating a potential upside of 116.80%. Given Nurix Therapeutics’ stronger consensus rating and higher probable upside, analysts clearly believe Nurix Therapeutics is more favorable than Creative Medical Technology.
Summary
Nurix Therapeutics beats Creative Medical Technology on 9 of the 13 factors compared between the two stocks.
About Creative Medical Technology
Creative Medical Technology Holdings, Inc. is a biotechnology company focused on developing regenerative medicine and cellular therapies. Its research programs are designed to use stem cells and other biological approaches to address conditions for which existing treatment options may be limited. The company has developed and investigated therapies based on autologous stem cells, meaning cells collected from and administered back to the same patient. Its programs have included CaverStem, a regenerative treatment candidate for erectile dysfunction, as well as investigational platforms such as FemCelz for female sexual dysfunction and ImmCelz, an immune-modulating cellular therapy platform.
About Nurix Therapeutics
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Francisco, California. Founded in 2009, it develops medicines that aim to treat cancer and other diseases by changing the levels of specific proteins inside cells. The company’s technology focuses on protein degradation, using the cell’s natural protein-disposal system to remove disease-related proteins. Nurix also researches ways to regulate protein activity through ubiquitin signaling, a process that helps control how proteins function and are broken down.
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
